Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. Kantarjian H, Short NJ, Haddad FG, Jain N, et al. J Clin Oncol 2024;42:4246-4251.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kantarjian H, Short NJ, Haddad FG, Jain N, et al. Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. J Clin Oncol 2024;42:4246-4251.
PMID: 39028925